Skip to main content
. 2024 Jan 29;24:89. doi: 10.1186/s12884-024-06258-9

Table 2.

Hemoglobin electrophoresis results

Results of hemoglobin electrophoresis HbA HbA2 HbAN1 HbC HbF HbS
Minor β- thalassemia 96,5 3,5
Minor β- thalassemia 95,7 4,3
Minor β- thalassemia 95,5 4,5
β- Thalassemia intermediar 71 7,8 21,2
Acquired elevation of HbF (anemic stress) 93,4 2,4 4,2
Acquired elevation of HbF (anemic stress) 95,2 2,6 2,2
Acquired elevation of HbF (diabetes) 96,2 2,7 1,1
Composite S/C sickle cell disease 0,7 4,1 41,5 5,2 48,5
Composite S/C sickle cell disease 1 2,7 39,3 13,6 43,4
Homozygous sickle cell disease (Transfusion context) 48,2 3,4 3 45,4
Homozygous sickle cell disease (Transfusion context) 47,3 2,8 4 45,9
Homozygous sickle cell disease (Transfusion context) 0 3,1 14 82,9
HbE variant (heterozygous) 72,1 2,9 25
HbC variant (heterozygous) 61,2 3,8 35
Delta chain variant (heterozygous) 97,5 1,6 0,9
Delta chain variant (heterozygous) 97,7 2,3
Iron deficiency (5 subjects) 97,6 (97,5;98,1) 2,4 (1,9;2,5)
Normal (9 subjects) 97,4 (97;97,6) 2,6 (2,4;2,7)

The table 2 presents the results in hemoglobin electrophoresis in the first column and the respective percentage of hemoglobin A (HbA), hemoglobin A2 (HbA2), hemoglobin AN1 (HbAN1), hemoglobin C (HbC), hemoglobin F (HbF), and hemoglobin S (HbS). For the iron deficiency and normal patients, data are expressed as median, first and third quartile